Fig. 4From: Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancerKRAS mutation detection in CD45 depleted blood. The KRAS G12D mutation was detected in 2 patients that tested negative for CTC by the CellSearch® systemBack to article page